Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
Lipodystrophy at the injection sites is most common local complication of insulin therapy. The history of its study started in 1926, when first cases of lipoatrophy at the sites of insulin injections were described. As we moved to human insulin and insulin analogues, immune mediated atrophic form of...
Main Authors: | Vadim V. Klimontov, Mikhail M. Lazarev, Andrey Ju. Letyagin, Dinara M. Bulumbaeva, Natalia P. Bgatova |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2020-06-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/12095 |
Similar Items
-
Insulin-induced lipohypertrophy: clinical and ultrasound characteristics
by: Vadim V. Klimontov, et al.
Published: (2018-09-01) -
Lipodystrophies from Insulin Injection: An Update of the Italian Consensus Statement of AMD-OSDI Study Group on Injection Technique
by: Sandro Gentile, et al.
Published: (2023-03-01) -
Lipodystrophy: Still an underdiagnosed complication of subcutaneous insulin administration
by: Mariana Barbosa, et al.
Published: (2022-03-01) -
Insulin‐derived amyloidosis without a palpable mass at the insulin injection site: A report of two cases
by: Terumasa Nagase, et al.
Published: (2020-07-01) -
Partial lipodystrophy of limbs in type 2 diabetes: A case report
by: Meet Shah, et al.
Published: (2021-01-01)